Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

Item

http://www.wikidata.org/entity/Q35120311

Q35120311

about

Current and emerging azole antifungal agents Plasticity of Candida albicans Biofilms In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species Epidemiology of invasive candidiasis: a persistent public health problem International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia Activities of available and investigational antifungal agents against rhodotorula species Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media.Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles.Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis In vitro activity of a new polyene, SPA-S-843, against yeasts.Collaborative study of antibiotic medium 3 and flow cytometry for identification of amphotericin B-resistant Candida isolates.Aspergillus infections in transplant recipients.Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991.Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility.Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method.Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.Antifungal susceptibility testing: practical aspects and current challenges.Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia.Detection of resistance to amphotericin B in Candida isolates by using Iso-Sensitest broth.Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.In vitro antifungal susceptibility testing.In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter Has antifungal susceptibility testing come of age?Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole

P2860

Q24550733-C855F93E-56E8-4FE8-A137-27EDF3296BDD Q26744150-0733C538-6C62-43EE-A2A8-44DB91E61A2D Q28345261-667B5DA3-FD32-4162-971C-C46729153DC7 Q28362760-DE4F868D-1735-48D9-8931-0E2BFD4F0535 Q29616758-1BD884B7-D098-4535-85EB-63D7B878A214 Q30453797-C6C673AC-2A81-4036-8059-DDAEEA927F08 Q33210616-42405B00-AA4D-4D37-88FD-F17E462C283B Q33677651-16BA8607-A375-4074-8BA5-F905FE81A23C Q33682433-5B7DC89F-2A80-44E1-83F3-0C8A3C17C4AB Q33683250-07576DD8-DB32-41CF-88B9-D6D051FD9D82 Q33690616-E9600162-6669-4BB5-A7A4-229488A8905F Q33702041-0BCF4E76-B55C-4BE8-9159-E73517F43FBA Q33714825-C06805A2-1013-482D-9017-044CAFCB2CDA Q33719294-4B718DB7-8299-4F80-931F-6470BB9C6089 Q33894467-9FE98A99-E513-4705-B517-77F031881A17 Q33959506-5AD5949D-66C5-47B0-892F-7BC57FA08806 Q33960284-0EE40F5E-8E23-4189-AE7B-09AFC6C2A405 Q33960454-1174E091-42AB-4142-B9D0-30C0740947B7 Q33962343-647A78CB-3FC5-4606-957A-E9CAFCB78A4F Q33963057-4B6DD5F2-B93F-4708-A4C8-F4A9D8BEE651 Q33969644-CB989222-0740-4F78-BA97-C52658D593A9 Q33969963-E4EC606A-28E6-4FCA-B3C3-67D3B56FE619 Q33971002-2531FF32-73CC-4E7A-B1DC-1675DBED92C0 Q33971884-F2517CCC-2346-4866-8660-215627D3D70C Q33974143-531A0B86-068C-4378-B233-92DD51C2280B Q33974286-287F5B26-FE36-43D7-9521-B5A7E6EC7420 Q33975757-7325EB81-9EAC-426B-BEAA-F398AF2ACB26 Q33976842-5A54EB40-E22C-4F49-9560-1346A47CBC16 Q33982529-EB2ABE0C-3CD6-4D1D-A945-0DF2A2ED316C Q34105231-2B6A1A18-D5AF-437B-865E-E6923E992EA2 Q34109559-B772D37D-78DE-4E5B-8F36-F7E0D961889E Q34112321-297D899B-1A81-4D2B-A560-BC8D50B437B7 Q34193850-85636D94-5889-4A09-8462-67C579476137 Q34335217-FE056934-E5C5-4977-BD64-B80879C1028F Q34452652-458781BF-06DB-41CA-8C62-2F55B7A307B5 Q34510359-20512D21-C732-461E-8A72-FFBB3EA0E6C6 Q34749162-25F9F9D3-7CFD-4C4C-9EAE-4B67A4E9D20F Q34883912-09BA90BE-9F7D-4809-ABD9-3FA48CDA61DA Q34923038-B645589A-9807-4AEC-9E52-A5D7C3495074 Q34941412-13CADC42-18F5-484E-87F1-CFC765138D86

P2860

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

Item

http://www.wikidata.org/entity/Q35120311

description

1995 nî lūn-bûn

@nan

1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu